Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Indazole-3-carboxylic acid | 25g Pack Size. Group: Building Blocks, Research Organics & Inorganics. Formula: C8H6N2O2. CAS No. 4498-67-3. Prepack ID : 14636980-25g. Molecular Weight : 162.15. |  |
| Indazole-3-carboxylic acid | 5g Pack Size. Group: Building Blocks, Research Organics & Inorganics. Formula: C8H6N2O2. CAS No. 4498-67-3. Prepack ID : 14636980-5g. Molecular Weight : 162.15. | |
| Indazole-4-carboxylic acid | 1g Pack Size. Group: Building Blocks, Organics. Formula: C8H6N2O2. CAS No. 677306-38-6. Prepack ID : 11011697-1g. Molecular Weight : 162.15. | |
| Indazole-5-carboxylic acid | 1g Pack Size. Group: Building Blocks. Formula: C8H6N2O2. CAS No. 61700-61-6. Prepack ID : 10319301-1g. Molecular Weight : 162.15. | |
| Indazole-6-carboxylic acid | 1g Pack Size. Group: Building Blocks, Organics. Formula: C8H6O2N2. CAS No. 704-91-6. Prepack ID : 57557552-1g. Molecular Weight : 162.15. | |
| 1-Boc-5-amino-1H-Indazole (CAS 129488-10-4) | 1-Boc-5-amino-1H-Indazole (CAS 129488-10-4). Uses: Pharmaceuticals, Personal Care, Industrial. Grades: Pharma, Cosmetic, Food, Feed, Technical. CAS No. 129488-10-4. Pack Sizes: Bulk. Cenik is your partner of choice for Hard-to-find chemicals. We don't just provide products, we supply solutions to your technical and regulatory specifications. |  Cenik Chemicals |
| 1-Methyl-1H-indazole | 1g Pack Size. Group: Organics, Research Organics & Inorganics. Formula: C8H8N2. CAS No. 13436-48-1. Prepack ID : 90030983-1g. Molecular Weight : 132.16. | |
| 5-IODO-1H-INDAZOLE | 5-IODO-1H-INDAZOLE Uses: Pharmaceutical Research and Development. Group: Iodides. CAS No. 55919-82-9. Pack Sizes: Enquire for MOQ. Categories: Nordmann UK Fine Chemicals suppliers (Formerly Melrob-Eurolabs). |  UK / EU / USA / Japan |
| 6-Amino-2,3-dimethyl-2H-indazole Hydrochloride | An impurity of Pazopanib, which is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms. Group: Pharmaceutical. Alternative Names: 2H-Indazol-6-amine, 2,3-dimethyl-, hydrochloride (1:1); 2H-Indazol-6-amine, 2,3-dimethyl-, monohydrochloride; 2,3-Dimethyl-2H-indazol-6-amine hydrochloride; 2,3-Dimethyl-6-amino-2H-indazole hydrochloride. CAS No. 635702-60-2. Pack Sizes: 100 g. Product ID: B1370-323943. Molecular formula: C9H12ClN3. Mole weight: 197.66. Custom synthesis is available. Send your inquiries for more information. |  London |
| 6- Iodo Indazole | 6- Iodo Indazole Uses: Pharmaceutical R&D. Group: Iodides. CAS No. 261953-36-0. Pack Sizes: Enquire for MOQ. Categories: NORDMANN UK Fine Chemicals Suppliers. | UK / EU / USA / Japan |
| Methyl 1H-indazole-3-carboxylate | Indazole-3-carboxylic Acid Methyl Ester has potential as application of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase. Also used in the preparation of indazole-pyridine based protain kinase/Akt inhibitors. Group: Pharmaceutical. Alternative Names: 1H-Indazole-3-carboxylic acid methyl ester; 3-(Methoxycarbonyl)-1H-indazole. CAS No. 43120-28-1. Pack Sizes: 500 g. Product ID: B1370-317339. Molecular formula: C9H8N2O2. Mole weight: 176.17. Custom synthesis is available. Send your inquiries for more information. | London |
| 1-Benzyl-1H-indazol-3-ol | Benzydamine Hydrochloride Impurity C is benzydamine intermediate. Group: Pharmaceutical. Alternative Names: 1-Benzyl-3-hydroxy-1H-indazole; 1-Benzyl-3-hydroxyindazole; 1,2-Dihydro-1-(phenylmethyl)-3H-indazol-3-one; 1-Benzyl-1,2-dihydro-3H-indazol-3-one; NSC 247064. CAS No. 2215-63-6. Pack Sizes: 1mg;1g;10g. Product ID: NP2768. Molecular formula: C14H12N2O. Mole weight: 224.26. Custom synthesis is available. Send your inquiries for more information. | London |
| Axitinib Impurity 2 | An impurity of Axitinib, a tyrosine kinase inhibitor used for the treatment of kidney cancer. Group: Pharmaceutical. Alternative Names: 2,2'-((6,6'-(2,4-Di(pyridin-2-yl)cyclobutane-1,3-diyl)bis(1H-indazole-6,3-diyl))bis(sulfanediyl))bis(N-methylbenzamide). CAS No. 1428728-83-9. Pack Sizes: 5 mg. Product ID: B2694-467092. Molecular formula: C44H36N8O2S2. Mole weight: 772.96. Custom synthesis is available. Send your inquiries for more information. | London |
| Benzydamine hydrochloride | Benzydamine hydrochlorid is structurally unrelated to the corticosteroids. The action of benzydamine may be mediated by the prostaglandin system. Uses: Anti-inflammatory agents. Group: Pharmaceutical. Alternative Names: AF864; AF 864; AF-864; Benzydamine HCl; Benzidamine hydrochloride; Benzindamine hydrochloride; {3-[(1-benzyl-1H-indazol-3-yl)oxy]propyl}dimethylamine hydrochloride; 3-((1-Benzyl-1H-indazol-3-yl)oxy)-N,N-dimethylpropan-1-amine hydrochloride; 1-Propanamine, N,N-dimethyl-3-((1-(phenylmethyl)-1H-indazol-3-yl)oxy)-, monohydrochloride; 1-Benzyl-3-(3-(dimethylamino)propoxy)-1H-indazole hydrochloride. CAS No. 132-69-4. Pack Sizes: 1mg;1g;10g. Product ID: NP2775. Molecular formula: C19H23N3O.HCl. Mole weight: 345.87. Custom synthesis is available. Send your inquiries for more information. | London |
| Granisetron | Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medull. Uses: Granisetron is an antagonist of serptpmom 5-ht3 receptor and could be used to relieve the nausea and vomiting symptom after receving chemotherapy by decreasing the activity of the vagus nerve. Group: Pharmaceutical. Alternative Names: 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide; 1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-, endo-; BRL 43694. CAS No. 109889-09-0. Pack Sizes: 1 g. Product ID: B0084-474340. Molecular formula: C18H24N4O. Mole weight: 312.42. Custom synthesis is available. Send your inquiries for more information. | London |
| MK-4827 (R-enantiomer) | MK-4827 (R-enantiomer) is the R form of MK-4827, which is a PARP inhibitor developed for the treatment of ovarian cancer. Group: Pharmaceutical. Alternative Names: (R)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide; Niraparib R-enantiomer; MK4827 R-enantiomer; MK 4827 R-enantiomer; MK-4827 R-enantiomer. CAS No. 1038915-58-0. Pack Sizes: 5 mg. Product ID: B0084-138719. Molecular formula: C19H20N4O. Mole weight: 320.396. Custom synthesis is available. Send your inquiries for more information. | London |
| MK-4827 tosylate | MK-4827 tosylate is a selective inhibitor of PARP1/PARP2 with IC50 of 3.8 nM/2.1 nM. It has a great activity in cancer cells with mutant BRCA-1 and BRCA-2, >330-fold selective against PARP3, V-PARP and Tank1. Group: Pharmaceutical. Alternative Names: (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide 4-methylbenzenesulfonate; MK-4827; MK-4827; MK4827; MK4827-tosylate; Niraparib tosylate. CAS No. 1038915-73-9. Pack Sizes: 100 mg. Product ID: B0084-463500. Molecular formula: C26H28N4O4S. Mole weight: 492.59. Custom synthesis is available. Send your inquiries for more information. | London |
| MLi-2 | MLi-2 is a potent, orally available and brain penetrant inhibitor of LRRK2 (IC50 = 0.76 nM) with excellent selectivity that shows >295-fold selectivity for over 300 kinases and a diverse panel of receptors and ion channels. Group: Pharmaceutical. Alternative Names: Merck lrrk2 inhibitor-2; MLi 2; MLi2; rel-3-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-4-pyrimidinyl]-5-[(1-methylcyclopropyl)oxy]-1H-indazole. CAS No. 1627091-47-7. Pack Sizes: 50 mg. Product ID: B1370-007291. Molecular formula: C21H25N5O2. Mole weight: 379.46. Custom synthesis is available. Send your inquiries for more information. | London |
| Niraparib | Niraparib is an inhibitor of PARP, which was approved by FDA for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy. Group: Pharmaceutical. Alternative Names: MK-4827; MK 4827; MK4827; (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide; ZEJULA; 2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide. CAS No. 1038915-60-4. Pack Sizes: 100 mg. Product ID: B0084-408479. Molecular formula: C19H20N4O. Mole weight: 320.396. Custom synthesis is available. Send your inquiries for more information. | London |
| 2-((3-Iodo-1H-indazol-6-yl)thio)-N-methylbenzamide | An impurity of Axitinib, a tyrosine kinase inhibitor used for the treatment of kidney cancer. Group: Pharmaceutical. Alternative Names: Benzamide, 2-[(3-iodo-1H-indazol-6-yl)thio]-N-methyl-. CAS No. 885126-34-1. Pack Sizes: 100 mg. Product ID: B2694-467100. Molecular formula: C15H12IN3OS. Mole weight: 409.25. Custom synthesis is available. Send your inquiries for more information. | London |
| A-674563 | A-674563 is an Akt1 inhibitor with Ki of 11 nM, modest potent to PKA and >30-fold selective for Akt1 over PKC. Group: Pharmaceutical. Alternative Names: A674563; A 674563; Benzeneethanamine, α-[[[5-(3-methyl-1H-indazol-5-yl)-3-pyridinyl]oxy]methyl]-, (αS)-; (αS)-α-[[[5-(3-Methyl-1H-indazol-5-yl)-3-pyridinyl]oxy]methyl]benzeneethanamine; (S)-1-((5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl)oxy)-3-phenylpropan-2-amine. CAS No. 552325-73-2. Pack Sizes: 10 mg. Product ID: B0084-307687. Molecular formula: C22H22N4O. Mole weight: 358.44. Custom synthesis is available. Send your inquiries for more information. | London |
| A-674563 dihydrochloride | A-674563, an Akt1 inhibitor with a Ki of 11 nM, is moderately potent against PKA and >30-fold selective for Akt1 over PKC. Group: Pharmaceutical. Alternative Names: A-674563 2HCl; Benzeneethanamine, α-[[[5-(3-methyl-1H-indazol-5-yl)-3-pyridinyl]oxy]methyl]-, hydrochloride (1:2), (αS)-; (αS)-α-[[[5-(3-Methyl-1H-indazol-5-yl)-3-pyridinyl]oxy]methyl]benzeneethanamine dihydrochloride; (S)-1-((5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl)oxy)-3-phenylpropan-2-amine hydrochloride; A 674563 dihydrochloride; A674563 dihydrochloride. CAS No. 2759293-92-8. Pack Sizes: 1mg;1g;10g. Product ID: 2759293-92-8. Molecular formula: C22H22N4O.2HCl. Mole weight: 431.36. Custom synthesis is available. Send your inquiries for more information. | London |
| A-674563 hydrochloride | A-674563 hydrochloride is a potent, orally available Akt1 inhibitor with Ki of 11 nM. Group: Pharmaceutical. Alternative Names: (S)-1-(5-(3-methyl-1H-indazol-5-yl)pyridin-3-yloxy)-3-phenylpropan-2-amine hydrochloride. CAS No. 2070009-66-2. Pack Sizes: 1mg;1g;10g. Product ID: 2070009-66-2. Molecular formula: C22H23ClN4O. Mole weight: 394.9. Custom synthesis is available. Send your inquiries for more information. | London |
| ABT-102 | ABT 102 is a selective transient receptor potential vanilloid 1 (TRPV1) receptor antagonist with IC50 values to be 5-7 nM. No recent reports of development identified for phase-I development in Pain in USA. Uses: Pain. Group: Pharmaceutical. Alternative Names: ABT 102; ABT-102; ABT102; CHEMBL398338; 1-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]-3-(1H-indazol-4-yl)urea. CAS No. 808756-71-0. Pack Sizes: 1mg;1g;10g. Product ID: 808756-71-0. Molecular formula: C21H24N4O. Mole weight: 348.44. Custom synthesis is available. Send your inquiries for more information. | London |
| AC480 | AC480, also known as BMS-599626, is an orally bioavailable inhibitor of the HER1, HER2 and HER4 tyrosine kinases (IC50 =22, 32 and 190 nM, respectively) with potential antineoplastic activity. BMS-599626 inhibits human epidermal growth factor receptors (HER) HER1, HER2 and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors. Group: Pharmaceutical. Alternative Names: BMS-599626; BMS 599626; BMS599626; AC 480; AC-480; Carbamic acid, N-[4-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]-, (3S)-3-morpholinylmethyl ester; (3S)-3-Morpholinylmethyl N-[4-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate; Carbamic acid, [4-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]-, (3S)-3-morpholinylmethyl ester; N-[4-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]-carbamic acid, (3S)-3-morpholinylmethyl ester. CAS No. 714971-09-2. Pack Sizes: 1mg;1g;10g. Product ID: B0084-259278. Molecular formula: C27H27FN8O3. Mole weight: 530.55. Custom synthesis is available. Send your inquiries for more information. | London |
| Axitinib | Axitinib (AG013736) is a tyrosine kinase inhibitor developed by Pfizer. Axitinib is a tyrosine kinase inhibitor that blocks the activation of VEGFR1, VEGFR2, VEGFR3, c-kit, and PDGFRβ (IC50 = 1.2, 0.25, 0.29, 1.7, and 1.6 nM, respectively). It has been shown to significantly inhibit growth of breast cancer in animal (xenograft) models. Uses: Protein kinase inhibitors. Group: Pharmaceutical. Alternative Names: AG 013736; N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-benzamide; Inlyta. CAS No. 319460-85-0. Pack Sizes: 5 g. Product ID: NP3631. Molecular formula: C22H18N4OS. Mole weight: 386.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Axitinib sulfoxide | A major metabolite of Axitinib, a tyrosine kinase inhibitor used for the treatment of kidney cancer. Group: Pharmaceutical. Alternative Names: N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]sulfinyl]-benzamide; Axitinib Impurity A. CAS No. 1347304-18-0. Pack Sizes: 10 mg. Product ID: B2694-467095. Molecular formula: C22H18N4O2S. Mole weight: 402.48. Custom synthesis is available. Send your inquiries for more information. | London |
| AZD-7594 | AZD-7594 is an inhaled selective glucocorticoid receptor (GCCR) modulator. Group: Pharmaceutical. Alternative Names: AZD-7594; AZD 7594; AZD7594; AZ13189620; AZ-13189620; AZ 13189620; 3-[5-[(1R,2S)-2-(2,2-difluoropropanoylamino)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)propoxy]indazol-1-yl]-N-[(3R)-oxolan-3-yl]benzamide. CAS No. 1196509-60-0. Pack Sizes: 10 mg. Product ID: B0084-260278. Molecular formula: C32H32F2N4O6. Mole weight: 606.627. Custom synthesis is available. Send your inquiries for more information. | London |
| CPI-637 | CPI-637 is a selective and cell-active benzodiazepinone CBP/EP300 bromodomain inhibitor with IC50 of 0.03±0.01μM and 11.0±0.6 μM for CBP/EP300 and BRD4, respectively. CPI-637 displayed a >700-fold selectivity over the BET family of bromodomains (BRD4 IC50 = 11.0 ± 0.6 μM). Group: Pharmaceutical. Alternative Names: CPI-637; CPI 637; CPI637. (4R)-4-methyl-6-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one; CPI-637; SCHEMBL17673230. CAS No. 1884712-47-3. Pack Sizes: 300 mg. Product ID: B0084-475488. Molecular formula: C22H22N6O. Mole weight: 386.459. Custom synthesis is available. Send your inquiries for more information. | London |
| Entrectinib | Entrectinib (RXDX-101) is an orally bioavailable pan-TrkA/B/C, ROS1 and ALK inhibitor with IC50 ranging between 0.1 and 1.7 nM. Phase 2. Uses: Protein kinase inhibitors. Group: Pharmaceutical. Alternative Names: RXDX101; RXDX 101; RXDX-101; NMS E628; NMS-E628; Entrectinib; N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide. CAS No. 1108743-60-7. Pack Sizes: 250 mg. Product ID: B0084-470812. Molecular formula: C31H34F2N6O2. Mole weight: 560.64. Custom synthesis is available. Send your inquiries for more information. | London |
| GDC0941 | GDC-0941 is a potent pan inhibitor of class I catalytic subunits of PI3K that inhibits p110α, β, δ, and γ with IC50 values of 3, 33, 3, and 75 nM. Group: Pharmaceutical. Alternative Names: 4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)morpholine; GDC-0941; GDC 0941; GDC0941; RG7321; RG-7321; RG 7321; GNE0941; GNE-0941; GNE 0941; Pictrelisib; Pictilisib. CAS No. 957054-30-7. Pack Sizes: 50 mg. Product ID: B0084-101126. Molecular formula: C23H27N7O3S2. Mole weight: 513.635. Custom synthesis is available. Send your inquiries for more information. | London |
| GSK583 | GSK583 is a selective receptor-interacting serine/threonine-protein kinase 2 (RIP2 Kinase) inhibitor and the RIP2K binding IC50 is 5 nM. GSK583 can inhibit both TNF-α and IL-6 production with an IC50 value of 200 nM in an ex vivo human translational model. Group: Pharmaceutical. Alternative Names: GSK583; GSK 583; GSK-583. 6 - (tert-Butylsulfonyl) - N - (5-fluoro - 1H - indazol-3-yl)quinolin-4-amine. CAS No. 1346547-00-9. Pack Sizes: 25 mg. Product ID: B0084-475334. Molecular formula: C20H19FN4O2S. Mole weight: 398.46. Custom synthesis is available. Send your inquiries for more information. | London |
| KD025 | KD025 is an orally available and selective ROCK2 inhibitor with IC50 value of 60 nM and Ki value of 41 nm, respectively. It was shown to suppress adipogenesis in human adipose-derived stem cells. Uses: Protein kinase inhibitors. Group: Pharmaceutical. Alternative Names: SLx 2119; SLx2119; KD-025; 2-[3-[4-(1H-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-N-propan-2-ylacetamide. CAS No. 911417-87-3. Pack Sizes: 100 mg. Product ID: B0084-460389. Molecular formula: C26H24N6O2. Mole weight: 452.51. Custom synthesis is available. Send your inquiries for more information. | London |
| MK-8353 | MK-8353 is an orally available ERK1/2 inhibitor. It exhibited antitumor activity in patients with BRAFV600-mutant melanoma. Group: Pharmaceutical. Alternative Names: (3S)-3-(methylthio)-1-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-N-[3-(6-propan-2-yloxy-3-pyridinyl)-1H-indazol-5-yl]-3-pyrrolidinecarboxamide. CAS No. 1184173-73-6. Pack Sizes: 50 mg. Product ID: B2693-291615. Molecular formula: C37H41N9O3S. Mole weight: 691.84. Custom synthesis is available. Send your inquiries for more information. | London |
| Pexmetinib | Pexmetinib (ARRY-614) is a potent, orally bioavailable, dual p38 MAPK/Tie-2 inhibitor with IC50 of 4 nM/18 nM in a HEK-293 cell line. It has potential antineoplastic, anti-inflammatory, and antiangiogenic activities. It inhibits other kinases including vascular endothelial growth factor receptor (VEGFR2) and Src tyrosine kinases. Group: Pharmaceutical. Alternative Names: 1-(3-(tert-Butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(5-fluoro-2-((1-(2-hydroxyethyl)-1H-indazol-5-yl)oxy)benzyl)urea; Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[[5-fluoro-2-[[1-(2-hydroxyethyl)-1H-indazol-5-yl]oxy]phenyl]methyl]-; N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[[5-fluoro-2-[[1-(2-hydroxyethyl)-1H-indazol-5-yl]oxy]phenyl]methyl]urea; ARRY 614; ARRY-614; ARRY614; N-(3-tert-Butyl-1-p-tolyl-1H-pyrazol-5-yl)-N'-[5-fluoro-2-[1-(2-hydroxyethyl)-1H-indazol-5-yloxy]benzyl]urea. CAS No. 945614-12-0. Pack Sizes: 50 mg. Product ID: B2693-470949. Molecular formula: C31H33FN6O3. Mole weight: 556.63. Custom synthesis is available. Send your inquiries for more information. | London |
| SCH772984 | SCH772984 is a potent and selective ERK inhibitor with potential anticancer activity. SCH722984 showed activity against BRAF mutant, NRAS mutant and wild-type melanoma. Combining vemurafenib and SCH722984 in BRAF mutant melanoma was synergistic in a majority of cell lines and significantly delayed the onset of acquired resistance in long term in vitro assays. Therefore, SCH772984 may be clinically applicable as a treatment for non-BRAF mutant melanoma or in BRAF-mutant melanoma with innate or acquired resistance, alone or in combination with BRAF inhibitors. Group: Pharmaceutical. Alternative Names: SCH-772984; SCH 772984; (R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide. CAS No. 942183-80-4. Pack Sizes: 25 mg. Product ID: B2693-429803. Molecular formula: C33H33N9O2. Mole weight: 587.688. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
